Guest guest Posted March 22, 2010 Report Share Posted March 22, 2010 I wanted to recap and further explain some of what has been said regarding this topic. The important thing to remember is that it was not until the 80s that we had a reliable, and easy method for differentiating T cells from B cells. Under the microscope they appear identical. The classification scheme that was used until 1994 did not even distinguish T cell from B cell lymphomas (The National Cancer Institute Working Group). In 1994, the REAL (Revised European American Lymphoma) Classification separated CLL into T-CLL and B-CLL. (It also combine CLL and SLL.) As diagnostic methods improved, it became clear that T-CLL really is a mix of different tumors, and that a true CLL diagnosis requires a B cell phenotype. Previous cases of " T-CLL " were better described as mycosis fungoides, ATLL, etc. This is when B-CLL became CLL. It is important to not get confused the CLL of 2002 WHO (World Health Organization) Classification with the CLL of the 1982 NCI Working Group (NCI-WG). The NCI-WG CLL is a term applied to all patients with an increased lymphocyte count that contain mature appearing lymphocytes. This included a mix of T cell, B cell, and NK cell malignancies. In the WHO Classification, CLL refers to a lymphoma that is specifically B cell. Prolymphocyte leukemia is a different entity and can be either B or T cell in type. B-PLL can arise new or from CLL and is characterized by havnig the cells appear with more cytoplasm and irregular nuclei. T-PLL is different in that it can contain cells that appear like normal T cells. It is important to remember that CLL patients are allowed to have prolymphocytes (up to 55%), so having some does not mean a PLL transformation. Rick Furman, MD Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.